Literature DB >> 22890769

First reported case of azole-resistant aspergillus fumigatus due to the TR/L98H mutation in Germany.

P-M Rath, D Buchheidt, B Spiess, E Arfanis, J Buer, J Steinmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22890769      PMCID： PMC3486539          DOI： 10.1128/AAC.01017-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  13 in total

1.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

2.  High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole.

Authors:  Pierre-Régis Burgel; Marie-Thérèse Baixench; Michaël Amsellem; Etienne Audureau; Jeanne Chapron; Reem Kanaan; Isabelle Honoré; Jean Dupouy-Camet; Daniel Dusser; Corné H Klaassen; Jacques F Meis; Dominique Hubert; André Paugam
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

3.  Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.

Authors:  Alexandre Alanio; Emilie Sitterlé; Martine Liance; Cécile Farrugia; Françoise Foulet; Françoise Botterel; Yosr Hicheri; Catherine Cordonnier; Jean-Marc Costa; Stéphane Bretagne
Journal:  J Antimicrob Chemother       Date:  2010-12-05       Impact factor: 5.790

4.  Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene.

Authors:  Shawn R Lockhart; João P Frade; Kizee A Etienne; Michael A Pfaller; Daniel J Diekema; S Arunmozhi Balajee
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

5.  Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance.

Authors:  Klaus Leth Mortensen; Rasmus Hare Jensen; Helle Krogh Johansen; Marianne Skov; Tacjana Pressler; Susan Julie Howard; Howard Leatherbarrow; Emilia Mellado; Maiken Cavling Arendrup
Journal:  J Clin Microbiol       Date:  2011-04-20       Impact factor: 5.948

6.  Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients.

Authors:  Birgit Spiess; Wolfgang Seifarth; Natalia Merker; Susan J Howard; Mark Reinwald; Anne Dietz; Wolf-Karsten Hofmann; Dieter Buchheidt
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

7.  Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain.

Authors:  Klaus Leth Mortensen; Emilia Mellado; Cornelia Lass-Flörl; Juan Luis Rodriguez-Tudela; Helle Krogh Johansen; Maiken Cavling Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2010-08-30       Impact factor: 5.191

Review 8.  Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection.

Authors:  Susan Julie Howard; Maiken Cavling Arendrup
Journal:  Med Mycol       Date:  2010-08-26       Impact factor: 4.076

9.  Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis.

Authors:  S J Howard; A C Pasqualotto; D W Denning
Journal:  Clin Microbiol Infect       Date:  2009-08-07       Impact factor: 8.067

10.  Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009.

Authors:  Jan W M van der Linden; Eveline Snelders; Greetje A Kampinga; Bart J A Rijnders; Eva Mattsson; Yvette J Debets-Ossenkopp; Ed J Kuijper; Frank H Van Tiel; Willem J G Melchers; Paul E Verweij
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883
View more
  17 in total

1.  Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection model.

Authors:  Seyedmojtaba Seyedmousavi; Roger J M Brüggemann; Jacques F Meis; Willem J G Melchers; Paul E Verweij; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

Review 2.  The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back.

Authors:  Xiaolei Wei; Yuanwei Zhang; Ling Lu
Journal:  J Microbiol       Date:  2015-01-28       Impact factor: 3.422

Review 3.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

4.  Environmental isolates of azole-resistant Aspergillus fumigatus in Germany.

Authors:  Oliver Bader; Jana Tünnermann; Anna Dudakova; Marut Tangwattanachuleeporn; Michael Weig; Uwe Groß
Journal:  Antimicrob Agents Chemother       Date:  2015-05-04       Impact factor: 5.191

5.  Is azole resistance in Aspergillus fumigatus a problem in Spain?

Authors:  Pilar Escribano; Teresa Peláez; Patricia Muñoz; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

Review 6.  Recent developments in the management of invasive fungal infections in patients with oncohematological diseases.

Authors:  Markus Ruhnke; Stefan Schwartz
Journal:  Ther Adv Hematol       Date:  2016-07-01

7.  Posaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosis.

Authors:  Seyedmojtaba Seyedmousavi; Johan W Mouton; Willem J G Melchers; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

8.  In Vivo Efficacy of Liposomal Amphotericin B against Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates in Two Different Immunosuppression Models of Invasive Aspergillosis.

Authors:  Seyedmojtaba Seyedmousavi; Johan W Mouton; Willem J G Melchers; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

9.  First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.

Authors:  K M T Astvad; R H Jensen; T M Hassan; E G Mathiasen; G M Thomsen; U G Pedersen; M Christensen; O Hilberg; M C Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

Review 10.  Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Authors:  Anna Dudakova; Birgit Spiess; Marut Tangwattanachuleeporn; Christoph Sasse; Dieter Buchheidt; Michael Weig; Uwe Groß; Oliver Bader
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.